Navigation Links
ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Tuesday, July 10, 2007 at 3:00 p.m. at the Mandarin Oriental Hotel in New York, NY. A live audio webcast of the presentation will be available on the Investor Information section of the ViaCell website at http://www.viacellinc.com. A replay of the presentation will be available for approximately three months after the webcast.

About ViaCell

ViaCell, Inc. is a biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord(R), a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases. ViaCell also conducts research and development primarily to investigate other potential therapeutic uses of umbilical cord blood-derived stem cells and on technology for expanding populations of these cells. ViaCell's pipeline is focused in the areas of cancer, cardiac disease, diabetes and fertility. For more information about ViaCell, visit our website at http://www.viacellinc.com. ViaCell(R) and ViaCord(R) are registered trademarks of ViaCell, Inc.

Contact

ViaCell, Inc.
Justine E. Koenigsberg, 617-914-3494
Senior Director, Corporate Communications


'"/>




Page: 1

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
9. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2019)... ST. LOUIS (PRWEB) , ... ... ... healthcare industry leader in delivering solutions designed for improved financial, operational and ... Officer, has earned the Fellow designation from the American College of Healthcare ...
(Date:12/2/2019)... ... 2019 , ... A Better Life Recovery, a leading addiction ... facility, announced it has named Tim Ryan and Jennifer Gimenez as the facility's ... , "We are proud to announce that Jennifer and Tim have joined our ...
(Date:12/2/2019)... ... December 02, 2019 , ... TopConsumerReviews.com recently awarded their highest ... at supporting Women’s Fertility and healthy natural ovulation. , Millions of couples long ... than for others. Factors like weight, medical conditions, age, and even stress can ...
Breaking Medicine Technology:
(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) has named Kymberly ... AHN from WVU Medicine in May 2018, previously served as AHN’s Vice Chair of ... chair since October and is also part of the pathology faculty at Drexel University ...
(Date:12/6/2019)... ... ... Dr. Scott Howell, a 2019 graduate of Trident University International’s (Trident) ... coconut oil in the 7 November 2019 edition of Progress in Cardiovascular Diseases ... Literature Review,” led by Dr. Hector O. Santos, examines the effect of coconut oil ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... from launching exceptional products that help people embrace, achieve, and maintain a healthy ... never been more committed to our mission of impacting world health, so it’s ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare ... Awards™, the only national awards dedicated to recognizing excellence in the areas of ... were presented in nine different categories during the GlobeSt Healthcare Conference today in ...
(Date:12/2/2019)... ... 02, 2019 , ... TrialScope, the global leader in clinical ... American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch ... inform patients, caregivers, the public, patient advocacy groups and healthcare professionals (HCPs) about ...
Breaking Medicine News(10 mins):